PAPER
Homochiral C3-Symmetric Triols and Triamines
285
(S)-1,3,5-Tris(2-hydroxy-2-methylbut-3-oxymethylene)-2,4,6-
trimethylbenzene (5)
and the solvent removed under reduced pressure. The residue was
purified by column chromatography eluting with CH2Cl2/MeOH/
NH3 (80:19:1) to yield the triamine 10, which was identified by 1H
NMR, but could not be fully purified.
1H NMR: d = 7.40-7.25 (15 H, m, 3 C6H5), 4.43 (3 H, d, Jα,β = 10.4
Hz, ArCHαHβ), 4.27 (3 H, d, partially obscured, ArCHαHβ), 4.26 (3
H, d, partially obscured, 3 OCH), 3.44-3.32 (3 H, m, 3 NH), 2.75-
2.70 (3 H, m, 3 NCH), 2.29 (9 H, s, 3 ArCH3), 2.21 (9 H, s, 3 NCH3),
1.07 (9 H, d, J = 6.4 Hz, 3 CH3).
Methylmagnesium bromide (4.3 mL, 3.0 M in Et2O, 12.9 mmol)
was added dropwise to a solution of the triester 4 (450 mg, 0.96
mmol) in anhyd Et2O (30 mL). The mixture was heated to reflux for
4 h then allowed to cool and stirred at r.t. for 16 h. The mixture was
cooled to 0°C and satd aq NH4Cl solution (10 mL) was added drop-
wise. The resulting layers were separated and the aqueous layer was
extracted with Et2O (3 î 30 mL). The organic phases were com-
bined and washed with satd aq NaCl solution (20 mL), dried
(MgSO4) and the solvent removed under reduced pressure. The
crude product could be purified either by recrystallising from Et2O
or by column chromatography (Rf 0.45, EtOAc/hexane, 3:2) to
yield the triol 5 as white needles (281 mg, 63%); mp 130-132°C.
1H NMR: d = 4.72 (3 H, d, Jα,β = 10.1 Hz, ArCHαHβ), 4.39 (3 H, d,
Jβ,α = 10.1 Hz, ArCHαHβ), 3.38 (3 H, q, J = 6.4 Hz, 3 CH), 2.44 (9
H, s, 3 ArCH3), 1.24 (9 H, d, J = 6.4 Hz, 3 CH3), 1.19 (9 H, s, 3 CH3),
1.11 (9 H, s, 3 CH3).
13C NMR: d = 138.3, 133.1 (Carom), 82.3 (CH), 72.7 (COH), 66.0
(ArCH2), 26.2 (CH3), 23.6 (CH3), 15.8 (ArCH3), 13.8 (CH3).
(1R,2S)-1,3,5-Tris(2-N,N-Dimethylamino-1-phenylprop-1-
oxymethylene)-2,4,6-trimethylbenzene (12)
NaH (0.36 g, 7.5 mmol, 50% dispersion in oil) was added with cool-
ing to a solution of (1R,2S)-(-)-methylephedrine (11; 1.35 g, 7.5
mmol) in THF (20 mL), and the mixture stirred for 30 min before
the catalyst Bu4NI (0.28 g, 0.75 mmol) and the tribromide 1 (1.00 g,
2.5 mmol) were added. The mixture was heated to reflux overnight,
filtered and the solvent removed under reduced pressure. The resi-
due was purified by column chromatography eluting with CH2Cl2/
MeOH/NH3 (90:9:1, Rf 0.7) to yield the triamine 12 as a viscous oil
which slowly crystallised on standing (0.92 g, 53%); mp 100-
102°C.
IR: n = 3384 (OH), 2981, 2932, 2880 (CH, alkyl), 1459, 1383,
1367, 1331 (C-OH), 1171, 1097, 1073 cm-1 (C-O)
MS: m/z (%) = 492 (M+ + Na, 10), 207 (C12H15O3, 6), 191
(C12H15O2, 9), 175 (C12H15O, 29), 157 (MH33+, 100), 144 (C11H12,
55).
1H NMR: d = 7.38-7.25 (15 H, m, 3 C6H5), 4.75 (3 H, d, J = 6.4 Hz,
OCH), 4.33 (3 H, d, Jα,β = 10.5 Hz, ArCHαHβ), 4.24 (3 H, d, Jβ,α
=
10.5 Hz, ArCHαHβ), 2.81 (3 H, quin, J = 6.4 Hz, 3 NCH), 2.21 [18
H, s, 3 N(CH3)2], 2.15(9 H, s, 3 ArCH3), 1.72 (9 H, d, J = 6.8 Hz, 3
CH3).
Anal. calcd for C27H48O6: C, 69.2; H, 10.3. Found: C, 69.4; H, 10.2.
13C NMR: d = 141.9, 138.4, 132.8 (Carom), 128.2, 127.5 (CHarom),
84.5 (OCH), 66.1 (ArCH2), 64.5 (NCH), 41.2 [N(CH3)2], 15.8
(ArCH3), 8.22 (CH3).
(S)-1,3,5-Tris(1,1-diphenyl-1-hydroxyprop-2-oxymethylene)-
2,4,6-trimethylbenzene (6)
Phenylmagnesium bromide (4.8 mL, 3.0 M in Et2O, 14 mmol) was
added dropwise to a solution of the triester 4 (500 mg, 1.07 mmol)
in anhyd Et2O (30 mL). The mixture was heated to reflux for 16 h,
cooled to 0°C and satd aq NH4Cl solution (10 mL) was added drop-
wise. The resulting layers were separated and the aqueous layer was
extracted with Et2O (3 î 30 mL). The combined organic phases
were washed with satd aq NaCl solution (20 mL), dried (MgSO4)
and the solvent removed under reduced pressure. The crude product
was purified by column chromatography (Rf 0.4, EtOAc/hexane,
1:4) to yield the triol 6 as colourless needles (482 mg, 57%); mp
90-92°C.
1H NMR: d = 7.55-7.50 (6 H, m, ArH), 7.44-7.40 (6 H, m, ArH),
7.25-7.11 (18 H, m, ArH), 4.52-4.48 (6 H, m, 3 CH and Ar-
CHαHβ), 4.29-4.24 (3 H, m, ArCHαHβ), 1.85, 1.77, 1.76 (9 H,
3 x s, 3 ArCH3), 1.12 (9 H, d, J = 5.8 Hz, 3 CH3).
13C NMR: d = 146.9, 146.8, 144.2, 138.8, 138.7, 132.3, 132.3
(Carom), 128.1, 128.0, 126.6, 125.9, 125.5 (CHarom), 80.0 (COH),
78.6, 78.5, 78.3 (CH), 65.9 (ArCH2), 15.0 (ArCH3), 14.9 (ArCH3),
13.5 (CH3).
IR: n = 3083, 3064, 3030 (CH, aromatic), 2968, 2932, 2906, 2867,
2822 (CH, alkyl), 1493, 1472, 1454 (CH, alkyl), 1269, 1187, 1132
(C-O), 761, 746 cm-1 (CH, aromatic).
MS: m/z = 694 (MH+, 100%), 516 (MH+ - C11H16NO, 55), 354
(MH+ - C22H32N2O, 10), 338 (MH+ - C22H32N2O2, 38), 176 (MH+
- C33H48N3O2, 33), 160 (MH+ - C33H48N3O3, 64).
HRMS (FAB): m/z calcd for C45H64N3O3 (M++H): 694.4948.
Found: 694.4955.
(1R,2S)-1,3,5-Tris[2-N-methylamino-1-phenylprop-1-oxymeth-
ylene]-2,4,6-trimethylbenzene (13)
(1R,2S)-(-)-Ephedrine (9; 1.24 g, 7.5 mmol) and Et3N (0.76 g, 7.51
mmol) were added to a solution of the tribromide 1 (1.00 g, 2.50
mmol) in chlorobenzene (10 mL). The mixture was stirred at r.t. for
1 h. The resulting precipitate was removed by filtration and the sol-
vent removed from the filtrate under reduced pressure at 100°C. The
residue was purified by column chromatography eluting with
CH2Cl2/MeOH/NH3 (90:9:1, Rf 0.5) to give the triol 13 as white
needles (1.36 g, 84%); mp 70-72°C.
IR: n = 3477 (OH), 3087, 3057, 3025 (CH, aromatic), 2977, 2932,
2909, 2897, 2784 (CH, alkyl), 1492, 1449 (CH, alkyl), 1373, 1316
(C-OH), 1172, 1093, 1041, 1032(C-O), 700 cm-1 (CH, aromatic).
MS: m/z (%) = 863 (M+ + Na, 8), 368 (80), 272 (55), 157 (70), 133
1H NMR: d = 7.25-7.11 (15 H, m, 3 C6H5), 4.58 (3 H, d, J = 6.1 Hz,
OCH), 3.91 (3 H, d, Jα,β = 13.1 Hz, ArCHαHβ), 3.71 (3 H, d, Jβ,α
=
13.1 Hz, ArCHαHβ), 2.86 (3 H, dq, J = 6.2, 6.6 Hz, 3 NCH), 2.17 (9
H, s, 3 NCH3), 2.05 (9 H, s, 3 ArCH3), 1.12 (9 H, d, J = 7.0 Hz, 3
CH3).
13C NMR: d = 142.9, 137.5, 133.2 (Carom), 127.8, 126.7, 126.4
(CHarom), 74.7 (OCH), 60.2 (CH2), 53.7 (NCH), 36.9 (NCH3), 16.3
(ArCH3), 10.0 (CH3).
(100).
HRMS (FAB): m/z calcd for C57H60NaO6 (M+ + Na): 863.4287.
Found: 863.4279.
(1R,2S)-1,3,5-Tris(2-N-methylamino-1-phenylprop-1-oxymeth-
ylene)-2,4,6-trimethylbenzene (10)
IR: n = 3420 (OH), 3027 (CH, aromatic), 2963, 2920, 2870 (CH,
alkyl), 1451 (CH, alkyl), 1383, 1354, 1264 (C-O), 760, 710 cm-1
(CH, aromatic).
NaH (360 mg, 7.5 mmol, 50% dispersion in oil) was added with
cooling to a solution of (1R,2S)-(-)-ephedrine (9; 1.24 g, 7.5 mmol)
in anhyd THF (20 mL) and the mixture stirred for 30 min. before the
catalyst Bu4NI (280 mg, 0.75 mmol) and the tribromide 1 (1.0 g, 2.5
mmol) were added. The mixture was stirred at r.t. overnight, filtered
MS: m/z (%) = 651 (M+, 100), 634 (M+ - OH, 20), 487 (M+
-
C10H14NO, 49), 323 (M+ - C20H28N2O2, 61), 155 (37).
Synthesis 2000, No. 2, 281–288 ISSN 0039-7881 © Thieme Stuttgart · New York